Theravance Biopharma, Inc.
P/S (Price-to-Sales)
Price
Sales Per Share
P/S (Price-to-Sales)
| Fiscal Year | P/S (Price-to-Sales) | Sales Per Share | Price |
|---|---|---|---|
| Dec 2014 | 41.13x | $0.36 | $14.92 |
| Dec 2015 | 14.78x | $1.11 | $16.39 |
| Dec 2016 | 34.62x | $0.92 | $31.88 |
| Dec 2017 | 98.58x | $0.28 | $27.89 |
| Dec 2018 | 23.60x | $1.08 | $25.59 |
| Dec 2019 | 19.61x | $1.32 | $25.89 |
| Dec 2020 | 15.42x | $1.15 | $17.77 |
| Dec 2021 | 13.88x | $0.80 | $11.05 |
| Dec 2022 | 16.08x | $0.70 | $11.22 |
| Dec 2023 | 10.82x | $1.04 | $11.24 |
| Dec 2024 | 7.14x | $1.32 | $9.41 |
| Dec 2025 | 9.06x | $2.09 | $18.91 |